Young Jonathan bought AKRO
August 12, 2025 · Form 4 insider transaction
Young Jonathan bought 12,500 shares of Akero Therapeutics, Inc. at $21.10 per share, a transaction worth $263.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
12,500
Price
$21.10
Total value
$263.8K
InsiderYoung Jonathan
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 12, 2025
Filing dateAugust 13, 2025
Shares owned after209,984
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated April 29, 2025, previously adopted by the Reporting Person.